Matches in Wikidata for { <http://www.wikidata.org/entity/Q85947132> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q85947132 description "article scientifique (publié 2008)" @default.
- Q85947132 description "artikull shkencor i botuar më 01 janar 2008" @default.
- Q85947132 description "artículu científicu espublizáu en xineru de 2008" @default.
- Q85947132 description "im Jahr 2008 veröffentlichter wissenschaftlicher Artikel" @default.
- Q85947132 description "scientific article published on 01 January 2008" @default.
- Q85947132 description "wetenschappelijk artikel" @default.
- Q85947132 description "наукова стаття, опублікована в січні 2008" @default.
- Q85947132 name "Intravitreal bevacizumab (avastin) and ranibizumab (lucentis) for choroidal neovascularization overlying choroidal osteoma" @default.
- Q85947132 name "Intravitreal bevacizumab (avastin) and ranibizumab (lucentis) for choroidal neovascularization overlying choroidal osteoma" @default.
- Q85947132 name "Intravitreal bevacizumab (avastin) and ranibizumab (lucentis) for choroidal neovascularization overlying choroidal osteoma" @default.
- Q85947132 type Item @default.
- Q85947132 label "Intravitreal bevacizumab (avastin) and ranibizumab (lucentis) for choroidal neovascularization overlying choroidal osteoma" @default.
- Q85947132 label "Intravitreal bevacizumab (avastin) and ranibizumab (lucentis) for choroidal neovascularization overlying choroidal osteoma" @default.
- Q85947132 label "Intravitreal bevacizumab (avastin) and ranibizumab (lucentis) for choroidal neovascularization overlying choroidal osteoma" @default.
- Q85947132 prefLabel "Intravitreal bevacizumab (avastin) and ranibizumab (lucentis) for choroidal neovascularization overlying choroidal osteoma" @default.
- Q85947132 prefLabel "Intravitreal bevacizumab (avastin) and ranibizumab (lucentis) for choroidal neovascularization overlying choroidal osteoma" @default.
- Q85947132 prefLabel "Intravitreal bevacizumab (avastin) and ranibizumab (lucentis) for choroidal neovascularization overlying choroidal osteoma" @default.
- Q85947132 P1433 Q85947132-BB6F9B55-BD1E-4589-960C-EB0E809CB7EE @default.
- Q85947132 P1476 Q85947132-137AEC60-6719-488B-A0D5-45E894E3EEE1 @default.
- Q85947132 P2093 Q85947132-45AE23DC-B60D-4BC3-A7B4-549F581D5DA5 @default.
- Q85947132 P2093 Q85947132-9250E88A-279F-4BCD-92CC-2FC25F2D90EA @default.
- Q85947132 P2093 Q85947132-BAEE9460-F7AC-4AD5-8C28-D0738C4F178A @default.
- Q85947132 P304 Q85947132-74526F97-3483-4ECF-8A0C-DF0EE81050C1 @default.
- Q85947132 P31 Q85947132-B37B5D5B-69C1-4BA7-9A3E-47026A051EAD @default.
- Q85947132 P356 Q85947132-6C3B02F6-998F-4571-BF36-C0562D62D954 @default.
- Q85947132 P433 Q85947132-89F92267-71A2-4EBB-AF7B-35C8181E95A2 @default.
- Q85947132 P478 Q85947132-8142F099-4996-4B69-8664-8F3A42FB7141 @default.
- Q85947132 P50 Q85947132-77EABD05-5BE7-4AC5-B734-7D36CE44F041 @default.
- Q85947132 P50 Q85947132-B16112E2-9FA9-483F-965A-4CAE1C82216F @default.
- Q85947132 P577 Q85947132-9ADFBB13-0CC0-4EB2-B80B-019222F3270C @default.
- Q85947132 P698 Q85947132-D38D715F-2E5C-493D-BE48-990915035A5A @default.
- Q85947132 P921 Q85947132-E01A670C-6C3D-45F1-88D1-0F746A98A59D @default.
- Q85947132 P356 ICB.0B013E318150D71B @default.
- Q85947132 P698 25389607 @default.
- Q85947132 P1433 Q15759926 @default.
- Q85947132 P1476 "Intravitreal bevacizumab (avastin) and ranibizumab (lucentis) for choroidal neovascularization overlying choroidal osteoma" @default.
- Q85947132 P2093 "Hakan Demirci" @default.
- Q85947132 P2093 "Pedro F Salazar" @default.
- Q85947132 P2093 "William E Benson" @default.
- Q85947132 P304 "18-20" @default.
- Q85947132 P31 Q13442814 @default.
- Q85947132 P356 "10.1097/ICB.0B013E318150D71B" @default.
- Q85947132 P433 "1" @default.
- Q85947132 P478 "2" @default.
- Q85947132 P50 Q5044560 @default.
- Q85947132 P50 Q6183174 @default.
- Q85947132 P577 "2008-01-01T00:00:00Z" @default.
- Q85947132 P698 "25389607" @default.
- Q85947132 P921 Q413299 @default.